Stocks · News reference
Health In Tech Q2 EPS $(0.04) Misses $(0.03) Estimate, Sales $8.057M Beat $7.547M Estimate
Health In Tech (NASDAQ:HIT) reported quarterly losses of $(0.04) per share which missed the analyst consensus estimate of $(0.03) by 100 percent. This is a 500 percent decrease over earnings of $0.01 per share from the
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Maxim Group Maintains Buy on Health In Tech, Lowers Price Target to $3
Maxim Group analyst Allen Klee maintains Health In Tech (NASDAQ:HIT) with a Buy and lowers the price target from $4 to $3.
Health In Tech Q2 2026 Earnings Call: Complete Transcript
Health In Tech (NASDAQ:HIT) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and
8-K filing — Health In Tech, Inc. (HIT)
Filed: 2026-08-13 AccNo: 0001213900-26-089249 Size: 268 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits